(Q61978441)

English

Osteoprotegerin: a new therapeutic agent for the treatment of bone disease

scientific article published in December 2001

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Osteoprotegerin: a new therapeutic agent for the treatment of bone disease (English)

0 references

1 reference

3

Dominique Heymann

0 references

author name string

Eva Grimaud

series ordinal

1

0 references

Françoise Redini

series ordinal

2

0 references

language of work or name

English

0 references

publication date

1 December 2001

0 references

published in

Drug Discovery Today

0 references

volume

6

0 references

issue

23

0 references

page(s)

1241-1242

0 references

cites work

Cytokines, growth factors and osteoclasts

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902037-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

gp130 Cytokine family and bone cells

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902037-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular biology of bone-resorbing cells.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902037-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902037-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902037-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902037-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902037-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902037-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucocorticoid decreases circulating osteoprotegerin (OPG): possible mechanism for glucocorticoid induced osteoporosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902037-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum parathyroid hormone, but not menopausal status, is associated with the expression of osteoprotegerin and RANKL mRNA in human bone samples.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902037-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Adenoviral delivery of osteoprotegerin ameliorates bone resorption in a mouse ovariectomy model of osteoporosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902037-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902037-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer cells responsible for humoral hypercalcemia express mRNA encoding a secreted form of ODF/TRANCE that induces osteoclast formation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902037-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902037-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902037-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902037-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Receptor activator of nuclear factor-kappaB ligand and osteoprotegerin: potential implications for the pathogenesis and treatment of malignant bone diseases

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902037-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902037-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteoprotegerin: a link between osteoporosis and arterial calcification?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902037-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of a single dose of osteoprotegerin in postmenopausal women

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2902037-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S1359-6446(01)02037-2

0 references

PubMed publication ID

11722878

0 references

(Q61978441)

Osteoprotegerin: a new therapeutic agent for the treatment of bone disease

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)